Prevalence of HIV-1 among recent arrestees in Los Angeles County, California: Serial cross-sectional study, 1991 to 1995

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 21, Issue 2, 1999, Pages 172-177

  Carpenter, Catherine L ^a   Longshore, Douglas ^b,c   Annon, Kiku ^b   Annon, Jeffrey J ^b   Anglin, M Douglas ^b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c RAND CORPORATION   (United States)

Author keywords

Arrestees; Drug abuse; HIV 1; Prevalence; Urine

Indexed keywords

ARTICLE; DRUG ABUSE; FEMALE; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEXUAL BEHAVIOR; SMOKING; UNITED STATES; URINALYSIS;

CRACK COCAINE; FEMALE; HIV ANTIBODIES; HIV INFECTIONS; HIV-1; HOMOSEXUALITY; HUMANS; LONGITUDINAL STUDIES; LOS ANGELES; MALE; ODDS RATIO; POPULATION SURVEILLANCE; PREVALENCE; PRISONERS; PRISONS; PROSTITUTION; RISK FACTORS; SEX FACTORS; SUBSTANCE ABUSE, INTRAVENOUS;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0033151579     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Elifson KW, Boles J, Sweat M. Risk factors associated with HIV infection among male prostitutes. Am J Public Health 1993;83:79-83.
2. Page JB, Chitwood DD, Smith PC, Kane N, McBride DC. Intravenous drug use and HIV infection in Miami. Med Anthropol Q 1992;6(3):56-71.
3. Wiebel WW, Jimenez A, Johnson W, et al. Risk behavior and HIV seroincidence among out-of-treatment injection drug users: a four-year prospective study. J Acquir Immune Defic Syndr Hum Retrovirol 1996;12:282-9.
4. Torres RA, Mani S, Althoz J, Brickner PW. Human immunodeficiency virus infection among homeless men in a New York City shelter. Arch Intern Med 1990;150:2030-6.
5. Stricof RI, Kennedy JT, Nattell TC, Weisfuse IB, Novick LF. HIV seroprevalence in a facility for runaway and homeless adolescents. Am J Public Health 1993;81(Suppl);50-3.
6. DesJarlais DC, Friedman SR, Novick DM, et al. HIV-1 infection among intravenous drug users in Manhattan, New York City, from 1977 through 1987. JAMA 1989;261(7):1008-12.
7. Selwyn PA, Hartel D, Wasserman W, Drucker E. Impact of the AIDS epidemic on morbidity and mortality among intravenous drug users in a New York City methadone maintenance program. Am J Public Health 1989;79:1358-62.
8. Robles RR, Colon HM, Diaz N, et al. Behavioural risk factors and HIV infection of injection drug users at detoxification clinics in Puerto Rico. Int J Epidemiol 1994;23:595-601.
9. Battjes RJ, Pickens RW, Brown Jr LS. HIV infections and AIDS risk behaviors among injection drug users entering methadone treatment: an update. J Acquir Immune Defic Syndr Hum Retrovirol 1995;10:90-6.
10. Prevots DR, Allen DM, Lehman JS, Green TA, Petersen LR, Gwinn M. Trends in human immunodeficiency virus seroprevalence among injection drug users entering drug treatment centers, United States, 1988-1993. Am J Epidemiol 1996;143:733-42.
11. McCray E, Onorato IM, and the Field Services Branch. Sentinel surveillance of human immunodeficiency virus infection in sexually transmitted disease clinics in the United States. Sex Transm Dis 1992;19(4):235-41.
12. Chirgwin K, DeHovitz JA, Dillon S, McCormack WM. HIV infection, genital ulcer diseases, and crack cocaine use among patients attending a clinic for sexually transmitted diseases. Am J Public Health 1991;81:1576-9.
13. Friedman SR, Jose B, Deren S, Des Jarlais DC, Neaigus A. Risk factors for Human Immunodeficiency Virus seroconversion among out-of-treatment drug injectors in high and low seroprevalence cities. Am J Epidemiol 1995;142:864-74.
14. Ungchusak K, Rehle T, Thammapornpilap P, Spiegelman D, Brinkman U, Siraprapasiri T. Determinants of HIV infection among female commercial sex workers in Northeastern Thailand: results from a longitudinal study. J Acquir Immune Defic Syndr Hum Retrovirol 1996;12:500-7.
15. Krai AH, Bluthenthal RN, Booth RE, Watters JK. HIV seroprevalence among street-recruited injection drug and crack cocaine users in 16 US municipalities. Am J Public Health 1998;88:108-13.
16. Statistical Analysis System (SAS). SAS Software Release for Windows, Release 6.12. Cary, NC: Statistical Analysis System, 1996.
17. Longshore D, Anglin MD, Annon TA, Fukui P, Asch J. Detection of HIV-1 antibody in urine specimens in a region of low HIV-1 prevalence [letter]. J Acquir Immune Defic Syndr 1992;5:947-8.
18. Wish ED, O'Neil JO, Baldau V. Lost opportunity to combat AIDS: drug abusers in the criminal justice system. In: Leukefeld CG, Battjes RJ, Amsel Z. AIDS and Intravenous drug use: future directions for community-based prevention research. NIDA Res Monogr 1990;93:187-209.
19. Decker S, Rosenfeld R. Intravenous drug use and the AIDS epidemic: findings from a 20-city sample of arrestees. Crime Delinq 1992;38:492-509.
20. Bellis MA, Weild AR, Beeching NJ, Mutton KJ, Syed Q. Prevalence of HIV and injecting drug use in men entering Liverpool prison. BMJ 1997;315:30-1.
21. Bird AG, Gore SM, Hutchinson SJ, Lewis SC, Cameron S, Burns S. Harm reduction measures and injecting inside prison versus mandatory drug testing: results of a cross sectional anonymous questionnaire survey. BMJ 1997;315:21-4.
22. Center for Disease Control and Prevention. HIV/AIDS Surveill Rep 1997;9:1-44.
23. Berrios D, Avins A, Haynew-Sanstad K, Eversley R, Woods W, Illulley SB. Screening for HIV antibody in urine [abstract]. VIII International AIDS Conference, Amsterdam, 1992.
24. Berrios DC, Avins AL, Haynes-Sanstad K, Eversley R, Woods WJ. Screening for Human Immunodeficiency Virus antibody in urine. Arch Pathol Lab Med 1995;119:139-41.
25. Calzavara LM, Major C, Myers T, et al. Reducing volunteer bias: using left-over specimens to estimate rates of HIV infection among inmates in Ontario, Canada. AIDS 1995;9:631-7.
26. Longshore D, Annon J, Anglin MD. HIV prevalence among injection drug users in three northern California communities. J Acquir Immune Defic Syndr Hum Retrovirol 1998;19:554.
27. Gellert GA, Maxwell RM, Higgins KV, Pendergast T, Wilker N. HIV infection in the Women's Jail, Orange County, California, 1985 through 1991. Am J Publ Health 1993;83:1454-6.
28. Holmberg SD. The estimated prevalence and incidence of HIV in 96 large US metropolitan areas. Am J Publ Health 1996;86:642-54.
29. Longshore D, Anglin MD, Henson KD, Annon K. HIV transmission and risk behavior among drug users in Los Angeles County, 1993 Update. Los Angeles: Department of Health Services Report, Los Angeles County, 1993.
30. Koester S, Booth RE, Zhang Y. The prevalence of additional injection-related HIV risk behaviors among injection drug users. J Acquir Immune Defic Syndr Hum Retrovirol 1996;12:202-7.
31. Shah SM, Shapshak P, Rivers JE, et al. Detection of HIV-1 DNA in needles/syringes, paraphernalia, and washes from shooting galleries in Miami: a preliminary laboratory report. J Acquir Immune Defic Syndr Hum Retrovirol 1996;11:301-6.
32. Larrat EP, Zierler S, Mayer K. Cocaine use and heterosexual exposure to human immunodeficiency virus. Epidemiol 1994;5:398-403.
33. De Hovitz JA, Kelly P, Feldman J, et al. Sexually transmitted diseases, sexual behavior, and cocaine use in inner-city women. Am J Epidemiol 1994;140:1125-34.
34. Jones DL, Irwin KL, Inciardi J, et al. The high-risk sexual practices of crack-smoking sex workers recruited from the streets of three American cities. Sex Transm Dis 1998;25:187-93.
35. Wiebel WW. Sampling issues for natural history studies including intravenous drug abusers. Longitudinal studies of HIV infection in intravenous drug users. NIDA Res Monogr 1991;109:51-62.